NHGRI logo

The National Human Genome Research Institute supports research and training and career development opportunities in support of its research mission which is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society.

Overview

To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR) , a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.

For how NHGRI will treat new and non-competing applications, see the FY2022 Funding Policy.

  • Overview

    To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR) , a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.

    For how NHGRI will treat new and non-competing applications, see the FY2022 Funding Policy.

NHGRI Funding Opportunities

  • Solicitation of Nominations for the 2022 National Human Genome Research Institute’s Outstanding Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
    NOT-HG-11-014

  • Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
    RFA-HG-22-002
    Application Due Dates: July 27, 2022
    Expiration Date: July 28, 2022

  • Notice of Intent to Publish a Funding Opportunity Announcement for An Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
    NOT-HG-22-012

  • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    PAR-22-107
    Application Due Dates: June 22, 2022; June 22, 2023; June 21, 2024
    Expiration Date: June 22, 2024

  • Notice of Early Termination of RFA-HG-21-033, Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)
    NOT-HG-22-003

  • Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients’ Use of Genomic Information
    NOT-HG-22-011

  • Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    RFA-HG-22-001
    Application Due Dates: March 04, 2022, February 28, 2023, February 27, 2024
    Expiration Date: February 28, 2024

  • New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
    RFA-HG-21-041
    Application Due Dates: February 22, 2022; February 22, 2023; February 22, 2024 
    Expiration Date: February 23, 2024 

  • Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    PAR-21-254
    Application Due Dates: February 5, June 5, October 5
    Expiration Date: September 8, 2024

  • Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    PAR-21-255
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: September 8, 2024

  • Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
    PAR-21-247
    Application Due Dates: October 1, 2021; June 15, 2022; June 15, 2023
    Expiration Date: June 16, 2023

  • Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
    RFA-HG-21-001
    Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 |
    Expiration Date: June 16, 2023
  • Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
    RFA-HG-21-002
    Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023
    Expiration Date: June 16, 2023
  • Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
    NOT-HG-21-018

  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)
    RFA-HG-21-006
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023

  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)
    RFA-HG-21-007
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023

  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
    RFA-HG-21-008
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023

  • Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
    NOT-HG-21-004

  • Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
    PAR-20-230
    Application Due Date(s): Applications are accepted by continuous receipt.
    Expiration Date: July 9, 2023
     
  • Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
    PAR-20-254
    Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
    Expiration Date: July 20, 2023
     
  • Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) Clinical Trial Optional)
    PAR-20-255
    Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023
    Expiration Date: July 20, 2023
     
  • Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
    PAR-20-257
    Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
    Expiration Date: July 20, 2023
  • Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
    RFA-HG-20-036
    Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
    Expiration Date: March 14, 2023

  • Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
    RFA-HG-20-037
    Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
    Expiration Date: March 14, 2023

  • Genomic Community Resources (U24)
    PAR-20-100
    Application Due Date(s): First due date is May 25, 2020; Standard dates apply after that, by 5:00 PM local time of applicant organization.
    Expiration Date: January 26, 2023
     
  • Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097)
    NOT-HG-20-017
     
  • Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
    NOT-HG-20-010
     
  • NHGRI Implementation of the NIH Genomic Data Sharing Policy
    NOT-HG-20-011
     
  • Notice of New NIH-Designated Data Repository: NHGRI’s Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)
    NOT-HG-19-02
  • NHGRI Funding Opportunities
    • Solicitation of Nominations for the 2022 National Human Genome Research Institute’s Outstanding Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
      NOT-HG-11-014

    • Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
      RFA-HG-22-002
      Application Due Dates: July 27, 2022
      Expiration Date: July 28, 2022

    • Notice of Intent to Publish a Funding Opportunity Announcement for An Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
      NOT-HG-22-012

    • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
      PAR-22-107
      Application Due Dates: June 22, 2022; June 22, 2023; June 21, 2024
      Expiration Date: June 22, 2024

    • Notice of Early Termination of RFA-HG-21-033, Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)
      NOT-HG-22-003

    • Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients’ Use of Genomic Information
      NOT-HG-22-011

    • Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
      RFA-HG-22-001
      Application Due Dates: March 04, 2022, February 28, 2023, February 27, 2024
      Expiration Date: February 28, 2024

    • New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
      RFA-HG-21-041
      Application Due Dates: February 22, 2022; February 22, 2023; February 22, 2024 
      Expiration Date: February 23, 2024 

    • Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
      PAR-21-254
      Application Due Dates: February 5, June 5, October 5
      Expiration Date: September 8, 2024

    • Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
      PAR-21-255
      Application Due Dates: February 16, June 16, October 16
      Expiration Date: September 8, 2024

    • Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
      PAR-21-247
      Application Due Dates: October 1, 2021; June 15, 2022; June 15, 2023
      Expiration Date: June 16, 2023

    • Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
      RFA-HG-21-001
      Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 |
      Expiration Date: June 16, 2023
    • Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
      RFA-HG-21-002
      Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023
      Expiration Date: June 16, 2023
    • Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
      NOT-HG-21-018

    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)
      RFA-HG-21-006
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023

    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)
      RFA-HG-21-007
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023

    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
      RFA-HG-21-008
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023

    • Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
      NOT-HG-21-004

    • Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
      PAR-20-230
      Application Due Date(s): Applications are accepted by continuous receipt.
      Expiration Date: July 9, 2023
       
    • Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
      PAR-20-254
      Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
      Expiration Date: July 20, 2023
       
    • Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) Clinical Trial Optional)
      PAR-20-255
      Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023
      Expiration Date: July 20, 2023
       
    • Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
      PAR-20-257
      Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
      Expiration Date: July 20, 2023
    • Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
      RFA-HG-20-036
      Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
      Expiration Date: March 14, 2023

    • Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
      RFA-HG-20-037
      Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
      Expiration Date: March 14, 2023

    • Genomic Community Resources (U24)
      PAR-20-100
      Application Due Date(s): First due date is May 25, 2020; Standard dates apply after that, by 5:00 PM local time of applicant organization.
      Expiration Date: January 26, 2023
       
    • Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097)
      NOT-HG-20-017
       
    • Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
      NOT-HG-20-010
       
    • NHGRI Implementation of the NIH Genomic Data Sharing Policy
      NOT-HG-20-011
       
    • Notice of New NIH-Designated Data Repository: NHGRI’s Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)
      NOT-HG-19-02

NIH-Wide Parent Funding Opportunities

  • PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    PA-22-176
    Expiration Date: April 6, 2023
  • PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    PA-22-177
    Expiration Date: April 6, 2023
  • PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    PA-22-178
    Expiration Date: April 6, 2023
  • PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    PA-22-179
    Expiration Date: April 6, 2023
  • NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
    RFA-RM-22-020
    Application Receipt Date(s): September 1, 2022
    Expiration Date: September 2, 2022
  • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
    PAR-21-357
    Expiration Date: January 8, 2025
  • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
    PAR-22-060
    Expiration Date: January 8, 2025

  • Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    PA-21-268 
    Expiration Date: June 30, 2024
     
  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
    PA-21-151
    Application Receipt Date(s): Multiple dates, see announcement.
    Expiration Date: January 8, 2024

    Plans to Promote Safe Environments at Conferences Supported by NIH Grants and Cooperative Agreements
    NOT-OD-22-074
     
  • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
    PA-20-272 
    Application Receipt Date(s): Multiple dates, see announcement.
    Expiration Date: July 24, 2023

    Guidance for NHGRI Grantees Requesting Administrative Supplements
     
  • Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
    PA-20-275 
    Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
    Expiration Date: July 24, 2023
     
  • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    PA-20-194
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: May 8, 2023
     
  • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
    PA-20-195
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: May 8, 2023
     
  • NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    PA-19-056
    Application Receipt Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2022
     
  • Research Project Grant (Parent R01 Clinical Trial Required)
    PA-19-055
    Application Receipt Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2022
     
  • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
    PAR-19-334
     
  • Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adoption of the Fast Healthcare Interoperability Resources (FHIR®) Standard
    NOT-OD-19-127
     
  • Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
    PA-18-590 
    Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
    Expiration Date: January 26, 2021
     
  • NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    PA-19-052
  • NIH-Wide Parent Funding Opportunities
    • PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
      PA-22-176
      Expiration Date: April 6, 2023
    • PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
      PA-22-177
      Expiration Date: April 6, 2023
    • PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
      PA-22-178
      Expiration Date: April 6, 2023
    • PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
      PA-22-179
      Expiration Date: April 6, 2023
    • NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
      RFA-RM-22-020
      Application Receipt Date(s): September 1, 2022
      Expiration Date: September 2, 2022
    • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
      PAR-21-357
      Expiration Date: January 8, 2025
    • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
      PAR-22-060
      Expiration Date: January 8, 2025

    • Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
      PA-21-268 
      Expiration Date: June 30, 2024
       
    • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
      PA-21-151
      Application Receipt Date(s): Multiple dates, see announcement.
      Expiration Date: January 8, 2024

      Plans to Promote Safe Environments at Conferences Supported by NIH Grants and Cooperative Agreements
      NOT-OD-22-074
       
    • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
      PA-20-272 
      Application Receipt Date(s): Multiple dates, see announcement.
      Expiration Date: July 24, 2023

      Guidance for NHGRI Grantees Requesting Administrative Supplements
       
    • Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
      PA-20-275 
      Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
      Expiration Date: July 24, 2023
       
    • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
      PA-20-194
      Application Due Dates: February 16, June 16, October 16
      Expiration Date: May 8, 2023
       
    • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
      PA-20-195
      Application Due Dates: February 16, June 16, October 16
      Expiration Date: May 8, 2023
       
    • NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
      PA-19-056
      Application Receipt Date(s): February 5, June 5, October 5
      Expiration Date: January 8, 2022
       
    • Research Project Grant (Parent R01 Clinical Trial Required)
      PA-19-055
      Application Receipt Date(s): February 5, June 5, October 5
      Expiration Date: January 8, 2022
       
    • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
      PAR-19-334
       
    • Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adoption of the Fast Healthcare Interoperability Resources (FHIR®) Standard
      NOT-OD-19-127
       
    • Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
      PA-18-590 
      Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
      Expiration Date: January 26, 2021
       
    • NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
      PA-19-052

NIH-Wide Topic Specific Funding Opportunities

  • Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
    RFA-NS-22-051
    Application Due Date(s): August 10, 2022
    Expiration Date: August 11, 2022
  • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    PAR-22-105
    Application Due Date(s): June 15, 2022, October 05, 2022, February 05, 2023, June 05, 2023, June 05, 2023, February 05, 2024, June 05, 2024, October 05, 2024, February 05, 2025
    Expiration Date: May 8, 2025
  • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    PAR-22-106
    Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, February 16, 2025, June 16, 2025
    Expiration Date: September 8, 2025
  • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    PAR-22-109
    Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023​​​​​​​, October 16, 2023​​​​​​​, February 16, 2024​​​​​​​, June 16, 2024, October 16, 2024
    Expiration Date: February 16, 2025
  • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    PAR-22-107
    Application Receipt Date(s): June 21, 2024
    Expiration Date: June 22, 2024
  • International Bioethics Research Training Program (D43 Clinical Trial Optional)
    PAR-22-116
    Application Receipt Date(s): June 6, 2024
    Expiration Date: June 7, 2024
     
  • International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
    PAR-22-118
    Application Receipt Date(s): June 6, 2024
    Expiration Date: June 7, 2024
  • Notice of Intent to Publish a Funding Opportunity Announcement for a Data Management and Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
    NOT-NS-22-071

  • Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
    NOT-OD-22-068

  • Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data
    NOT-OD-22-067

  • Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
    NOT-OD-22-069

  • Notice of Special Interest (NOSI): Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences
    NOT-OD-22-065

  • Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)
    NOT-HL-23-001

  • Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
    NOT-OD-22-026

  • Administrative Supplements to Promote Diversity in Research and Development  Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
    PA-21-345
    Application Due Dates: Rolling
    Expiration Date: September 10, 2024

  • Emerging Global Leader Award (K43 Independent Clinical Trial Required)
    PAR-21-251
    Application Due Dates: November 3, 2021, November 3, 2022, and November 3, 2023
    Expiration Date: December 12, 2023

  • Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
    PAR-21-252
    Application Due Dates: November 3, 2021, November 3, 2022, and November 3, 2023
    Expiration Date: December 12, 2023

  • Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications
    NOT-EB-20-017

  • Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
    NOT-EB-21-001
     
  • Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    NOT-MD-21-016
  • Notice Announcing the National Human Genome Research Institutes Expectation for Sharing Quality Metadata and Phenotypic Data
    NOT-HG-21-022

  • Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
    NOT-OD-21-011

  • Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
    NOT-OD-20-073

  • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
    PA-20-025
    Application Due Date(s): September 5, January 5, April 5
    Expiration Date: January 6, 2023

  • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    PAR-19-274
    Application Receipt/Submission Date(s): February 5, June 5, October 5
    Expiration Date: May 8, 2022

  • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    PAR-19-275
    Application Receipt/Submission Date(s): February 16, June 16, October 16
    Expiration Date: May 8, 2022

  • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    PAR-19-276
    Application Receipt/Submission Date(s): February 16, June 16, October 16
    Expiration Date: May 8, 2022

  • NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
    NOT-GM-19-021 
     
  • Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
    NOT-MD-19-001 
     
  • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health
    NOT-OD-18-149 
     
  • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health 
    NOT-OD-18-149 
     
  • Announcing the High-Priority, Short-Term Project Award (R56) 
    • Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" 
      NOT-HG-17-004 [grants.nih.gov]
  • NIH-Wide Topic Specific Funding Opportunities
    • Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
      RFA-NS-22-051
      Application Due Date(s): August 10, 2022
      Expiration Date: August 11, 2022
    • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
      PAR-22-105
      Application Due Date(s): June 15, 2022, October 05, 2022, February 05, 2023, June 05, 2023, June 05, 2023, February 05, 2024, June 05, 2024, October 05, 2024, February 05, 2025
      Expiration Date: May 8, 2025
    • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
      PAR-22-106
      Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, February 16, 2025, June 16, 2025
      Expiration Date: September 8, 2025
    • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
      PAR-22-109
      Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023​​​​​​​, October 16, 2023​​​​​​​, February 16, 2024​​​​​​​, June 16, 2024, October 16, 2024
      Expiration Date: February 16, 2025
    • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
      PAR-22-107
      Application Receipt Date(s): June 21, 2024
      Expiration Date: June 22, 2024
    • International Bioethics Research Training Program (D43 Clinical Trial Optional)
      PAR-22-116
      Application Receipt Date(s): June 6, 2024
      Expiration Date: June 7, 2024
       
    • International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
      PAR-22-118
      Application Receipt Date(s): June 6, 2024
      Expiration Date: June 7, 2024
    • Notice of Intent to Publish a Funding Opportunity Announcement for a Data Management and Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
      NOT-NS-22-071

    • Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
      NOT-OD-22-068

    • Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data
      NOT-OD-22-067

    • Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
      NOT-OD-22-069

    • Notice of Special Interest (NOSI): Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences
      NOT-OD-22-065

    • Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)
      NOT-HL-23-001

    • Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
      NOT-OD-22-026

    • Administrative Supplements to Promote Diversity in Research and Development  Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
      PA-21-345
      Application Due Dates: Rolling
      Expiration Date: September 10, 2024

    • Emerging Global Leader Award (K43 Independent Clinical Trial Required)
      PAR-21-251
      Application Due Dates: November 3, 2021, November 3, 2022, and November 3, 2023
      Expiration Date: December 12, 2023

    • Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
      PAR-21-252
      Application Due Dates: November 3, 2021, November 3, 2022, and November 3, 2023
      Expiration Date: December 12, 2023

    • Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications
      NOT-EB-20-017

    • Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
      NOT-EB-21-001
       
    • Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
      NOT-MD-21-016
    • Notice Announcing the National Human Genome Research Institutes Expectation for Sharing Quality Metadata and Phenotypic Data
      NOT-HG-21-022

    • Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
      NOT-OD-21-011

    • Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
      NOT-OD-20-073

    • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
      PA-20-025
      Application Due Date(s): September 5, January 5, April 5
      Expiration Date: January 6, 2023

    • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
      PAR-19-274
      Application Receipt/Submission Date(s): February 5, June 5, October 5
      Expiration Date: May 8, 2022

    • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
      PAR-19-275
      Application Receipt/Submission Date(s): February 16, June 16, October 16
      Expiration Date: May 8, 2022

    • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
      PAR-19-276
      Application Receipt/Submission Date(s): February 16, June 16, October 16
      Expiration Date: May 8, 2022

    • NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
      NOT-GM-19-021 
       
    • Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
      NOT-MD-19-001 
       
    • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health
      NOT-OD-18-149 
       
    • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health 
      NOT-OD-18-149 
       
    • Announcing the High-Priority, Short-Term Project Award (R56) 
      • Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" 
        NOT-HG-17-004 [grants.nih.gov]

Last updated: June 13, 2022